QRxPharma Limited

Type: Company
Name: QRxPharma Limited
First reported 8 hours ago - Updated 8 hours ago - 1 reports

Weekly Rise of 1.4% in Australia, Transurban to Raise $2.7 B

5:00 PM Sydney – Australian stocks extended gains for the third day in a row in a short trading week. Transurban plans to raise $2.74 billion to finance its $6.6 billion Queensland Motorways. Atlas Iron Ore shipped record iron ore in the quarter to M ... [Published 123Jump - 8 hours ago]
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Pfizer seeks wider Xeljanz indication

Actress, choreographer and So You Think You Can Dance judge Debbie Allen has signed on to participate with the drugmaker's type two diabetes awareness and wellness program.Sales rose 5% compared to the same period last year.Panel chair Randall Flick said ... [Published Medical Marketing And Media - 11 hours ago]
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Janssen recruits Debbie Allen for T2 Diabetes

The company expects to file an sNDA for plaque psoriasis next year.Sales rose 5% compared to the same period last year.Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine ... [Published Medical Marketing And Media - 11 hours ago]
First reported Apr 24 2014 - Updated Apr 24 2014 - 1 reports

Biotech bubble catching analysts off guard

When things go wrong at the speculative end of any sector, they go very wrong.Take the recently booming biotech sector. The challenge for investors is that the outcome is so often binary, and usually revolves around the regulatory approval or otherwise ... [Published Brisbane Times - Apr 24 2014]
First reported Apr 24 2014 - Updated Apr 24 2014 - 1 reports

Australia shares edge up to near 6-year high ahead of Anzac Day

* S&P/ASX200 trading up 0.2 pct at near 6-year high* Resources sector buoys market on rise in nickel prices* Gains capped by some stocks trading ex-dividend* Markets closed Friday for Anzac Day(Adds analysis, quotes, stocks on the move)By Thuy OngSYDNEY, ... [Published Yahoo! UK and Ireland - Apr 24 2014]
First reported Apr 23 2014 - Updated Apr 24 2014 - 9 reports

FDA Panel Votes to Recommend Against Approving Morphine-Oxycodone Opioid

An advisory panel of the Food and Drug Administration (FDA) voted Tuesday against approving a combination morphine-oxycodone painkiller, NPR reports. The drug, Moxduo, would be the first medication to combine both opioids in one capsule.Moxduo’s manufacturer, ... [Published Join Together - Apr 24 2014]
First reported Apr 23 2014 - Updated Apr 24 2014 - 1 reports

Australian Stock Market Report – Midday 4/23/14

MID-SESSION REPORT(12.15pm AEST)The Australian sharemarket is improving for the fifth day, with the All Ordinaries Index (XAO) up by 0.5 per cent. A little earlier, the All Ords was trading above the 5500pt mark for only the second time this calendar ... [Published International Business Times Australia - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Amgen sales rose by 5% in Q1

More in Business BriefsPanel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."The candidate would be the first to put oxycodone and morphine in one capsule.AbbVie's ... [Published Medical Marketing And Media - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 7 reports

US FDA Disapproval for a Painkiller pushes QRxPharma Share by 78%

After losing the approval of US regulatory panel for a painkiller that combines two opioids, QRxPharma Ltd. stock lost the most in Sydney trading since its initial share sale in 2007.A Food and Drug Administration advisory panel voted unanimously against ... [Published TopNews New Zealand - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

QRxPharma Snubbed Again, Illumina Shines, ENTA Gets Rich, LLY Opens Wallet

Allergan Inc. (AGN: Quote), which has received a takeover proposal from Valeant Pharmaceuticals International Inc. (VRX) (VRX.TO), touched an all-time high of $165.45 on Tuesday before closing at $163.35.The company noted that it will carefully review ... [Published RTTNews.com - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Midday: ASX trading up after CPI

(03:01)The ASX opened at its highest level since June 2008 this morning. Shares in QRxPharma Limited (ASX:QRX) plummet more than 75%. 23/ ... [Published Sydney Morning Herald - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 2 reports

QRxPharma plunges after US rejects painkiller

Shares in Australian pharmaceutical firm QRxPharma have plummeted 80 per cent in a major shareholder revolt after the company failed to win regulatory approval for its painkiller drug, Moxduo, to be released in the United States.QRxPharma shares are trading ... [Published Brisbane Times - Apr 23 2014]

Quotes

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."
"This is pure morphine and pure oxycodone," said Dr. Andrew Kolodny of the Phoenix House to NPR . "This is a product that is very easy to misuse. Very easy to crush and snort or crush and inject. So it's significantly more dangerous than the products that it would be competing with.”"
"The rules were changed during the course of development of this product. They ended up with a drug that they [the US FoodFood and Drug Administration] could not understand" Dr Holaday said

More Content

All (68) | News (63) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
Weekly Rise of 1.4% in Australia, Transurban to... [Published 123Jump - 8 hours ago]
Pfizer seeks wider Xeljanz indication [Published Medical Marketing And Media - 11 hours ago]
Janssen recruits Debbie Allen for T2 Diabetes [Published Medical Marketing And Media - 11 hours ago]
Biotech bubble catching analysts off guard [Published Brisbane Times - Apr 24 2014]
Australia shares edge up to near 6-year high ah... [Published Yahoo! UK and Ireland - Apr 24 2014]
FDA Panel Votes to Recommend Against Approving ... [Published Join Together - Apr 24 2014]
FDA Rejects Painkiller 'Moxduo,' As Voters Disa... [Published Medical Daily - Apr 23 2014]
QRxPharma slams US after drug rejected [Published Individual.com - Apr 23 2014]
FDA Advisors Reject Combination Pain Pill Moxduo [Published PT Community - Apr 23 2014]
Shares fall as US Food and Drug panel rejects n... [Published Sydney Morning Herald - Apr 23 2014]
Amgen sales rose by 5% in Q1 [Published Medical Marketing And Media - Apr 23 2014]
QRXPHARMA : CEO Discusses Moxduo® Advisory Comm... [Published 4 Traders - Apr 23 2014]
QRxPharma CEO Discusses Moxduo® Advisory Commit... [Published Noodls - Apr 23 2014]
FDA Panel Gives Combo Opioid Thumbs Down [Published General Medicine eJournal - Apr 23 2014]
US FDA Disapproval for a Painkiller pushes QRxP... [Published TopNews New Zealand - Apr 23 2014]
QRxPharma Issues Statement On Moxduo Advisory C... [Published Drugs.com - Apr 23 2014]
QRxPharma shares plunges as Moxduo faces FDA’s ... [Published The Utah People's Post - Apr 23 2014]
QRxPharma Snubbed Again, Illumina Shines, ENTA ... [Published RTTNews.com - Apr 23 2014]
Australian Stock Market Report – Midday 4/23/14 [Published International Business Times Australia - Apr 23 2014]
FDA Panel On Moxduo: Two Opioids Are Not Better... [Published Health News Daily - Apr 23 2014]
Midday: ASX trading up after CPI [Published Sydney Morning Herald - Apr 23 2014]
QRxPharma Plunges After U.S. Panel Fails to Bac... [Published Washington Post - Apr 23 2014]
FDA Panel On Moxduo: Two Opioids Are Not Better... [Published BioPortfolio - Apr 23 2014]
U.S. FDA Panel Rejects QRxPharma's First Drug, ... [Published BioPortfolio - Apr 23 2014]
QRxPharma plunges after US rejects painkiller [Published Brisbane Times - Apr 23 2014]
FDA Advisers Vote Against Approving New Opioid ... [Published KUNC 91.5 FM - Apr 23 2014]
FDA panel rejects pain pill Moxduo [Published King5.com - Apr 23 2014]
QRxPharma Pty Ltd. Fails To Win Panel Backing F... [Published BioSpace - Apr 23 2014]
QRxPharma Issues Statement on Moxduo® Advisory ... [Published Noodls - Apr 23 2014]
QRxPharma Issues Statement On Moxduo® Advisory ... [Published Financial Services - Apr 23 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Upcoming AdComms by Subject Matter [Published Eye on FDA - Apr 22 2014]
In prior years, near the end of a calendar year, FDA would put up a schedule of Tentative Advisory Committee Meetings with tentative meeting dates scheduled for each Advisory Committee.  This year, however, the calendar went up, but very few dates ...
1

Press Releases

sort by: Date | Relevance
QRxPharma Issues Statement On Moxduo® Advisory ... [Published Financial Services - Apr 23 2014]
QRxPharma Completes A$11.6 Million Capital Raising [Published Financial Services - Dec 13 2013]
QRxPharma Announces MOXDUO License Deal In Israel [Published Financial Services - Nov 27 2013]
QRxPharma Refiles MOXDUO® New Drug Application ... [Published Financial Services - Nov 26 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.